ArticleFrontiers in pharmacology2019

Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway.

Jin-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.